ID   SH-N
AC   CVCL_IY17
SY   SK-N-SH-N
DR   cancercelllines; CVCL_IY17
DR   Wikidata; Q54953222
RX   PubMed=3026862;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 12
//
RX   PubMed=3026862; DOI=10.1159/000163368;
RA   Sidell N., Sarafian T., Kelly M., Tsuchida T., Haussler M.;
RT   "Retinoic acid-induced differentiation of human neuroblastoma: a cell
RT   variant system showing two distinct responses.";
RL   Exp. Cell Biol. 54:287-300(1986).
//